cardiology careers collections past issues search home
     

This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Safety, Tolerability, and Initial Efficacy of AZD6140, the First Reversible Oral Adenosine Diphosphate Receptor Antagonist, Compared With Clopidogrel, in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome: Primary Results of the DISPERSE-2 Trial
J Am Coll Cardiol Cannon et al. 50: 1844

Cardiosource Slide Set

Cardiosource Slide Set





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal

 
  cardiology careers collections past issues search home